[Abstract #95] Role of Oncology Advanced Practitioners to Enhance Clinical Research

Christa M. Braun-Inglis, NP¹, Leigh M. Boehmer, PharmD², Laura J. Zitella, NP³, Brianna W. Hoffner, NP⁴, Yurii B. Shvetsov, PhD¹, Jessica M. Rhee, MD¹, Randall A. Oyer, MD⁵, Al B. Benson, III, MD⁶

¹University of Hawaii Cancer Center, Honolulu, HI; ²Association of Community Cancer Centers, Rockville, MD; ³University of California, San Francisco, CA; ⁴Harborside, Huntington, NY; ⁵Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, PA; ⁶Northwestern Medicine, Chicago, IL

Background

Oncology Advanced Practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants and pharmacists, are highly trained, skilled health care providers that contribute significantly to quality cancer care.

Given low clinical trial enrollment among adult oncology patients, understanding current research responsibilities of APs could lead to identification of opportunities to leverage this workforce to enhance accrual and conduct of clinical trials.

Access more clinical research and trials content in the 2020-21 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research.